BOUDREAUX GAIL
SEC CIK 1287920 · EDGAR
BoughtSold
Most active insiders at ELV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BOUDREAUX GAIL | Pres, CEO, Dir | $1.00M | — |
| 2 | Kendrick Charles Morgan JR | EVP, Pres, Commercial | — | $910.6K |
| 3 | COLLIS STEVEN H | Dir | $869.5K | — |
| 4 | Penczek Ronald W | CAO, Ctrl | — | $766.0K |
| 5 | PERU RAMIRO G | Dir | $366.1K | — |
| 6 | Dixon Robert L JR | Dir | — | $60.7K |
| 7 | SCHULMAN AMY W | Dir | — | $7,475 |
| 8 | Wessling Erin M | EVP, CLO | — | — |
| 9 | Craig Ryan R | EVP, Chief HR Off | — | — |
| 10 | Kaye Mark | EVP, CFO | — | — |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-07-17 13:50 | 2026-07-17 | ELV | Elevance Health | BOUDREAUX GAIL | Pres, CEO, Dir | P - Purchase | $367.79 | +2,725 | 172.0K | +2% | +$1.00M |
| 2026-03-13 | 2026-03-11 | TGT | Target Corporation | BOUDREAUX GAIL | Dir | A - Grant | $0.00 | +2,682 | 12.2K | +28% | $0 | |
| DM | 2026-03-04 | 2026-03-02+ | ELV | Elevance Health | BOUDREAUX GAIL | Pres, CEO, Dir | F - Tax | $292.01 | -8,449 | 169.3K | -5% | -$2.47M |
| DM | 2026-03-04 | 2026-03-02 | ELV | Elevance Health | BOUDREAUX GAIL | Pres, CEO, Dir | A - Grant | $0.00 | +26.7K | 171.0K | +18% | $0 |
| M | 2025-07-18 | 2025-07-18 | ELV | Elevance Health | BOUDREAUX GAIL | Pres, CEO, Dir | P - Purchase | $286.94 | +8,500 | 151.0K | +6% | +$2.44M |
| 2025-03-14 | 2025-03-12 | TGT | Target Corporation | BOUDREAUX GAIL | Dir | A - Grant | $0.00 | +2,946 | 9,067 | +48% | $0 | |
| DM | 2025-03-05 | 2025-03-03 | ELV | Elevance Health | BOUDREAUX GAIL | Pres, CEO, Dir | A - Grant | $0.00 | +26.2K | 142.5K | +23% | $0 |
| D | 2025-03-05 | 2025-03-03 | ELV | Elevance Health | BOUDREAUX GAIL | Pres, CEO, Dir | F - Tax | $395.50 | -10.4K | 116.3K | -8% | -$4.11M |
| M | 2024-07-23 | 2024-07-22 | ELV | Elevance Health | BOUDREAUX GAIL | Pres, CEO, Dir | S - Sale | $500.98 | -34.0K | 138.8K | -20% | -$17.03M |
| 2024-03-15 | 2024-03-13 | TGT | Target Corporation | BOUDREAUX GAIL | Dir | A - Grant | $0.00 | +1,873 | 5,918 | +46% | $0 | |
| DM | 2024-03-05 | 2024-03-01 | ELV | Elevance Health | BOUDREAUX GAIL | Pres, CEO, Dir | A - Grant | $0.00 | +42.9K | 160.7K | +36% | $0 |
| D | 2024-03-05 | 2024-03-01 | ELV | Elevance Health | BOUDREAUX GAIL | Pres, CEO, Dir | F - Tax | $499.11 | -19.3K | 117.8K | -14% | -$9.61M |
| 2023-03-10 | 2023-03-08 | TGT | Target Corporation | BOUDREAUX GAIL | Dir | A - Grant | $0.00 | +1,902 | 3,896 | +95% | $0 | |
| DM | 2023-03-03 | 2023-03-01 | ELV | Elevance Health | BOUDREAUX GAIL | Pres, CEO, Dir | A - Grant | $0.00 | +44.3K | 153.5K | +41% | $0 |
| DM | 2023-03-03 | 2023-03-01+ | ELV | Elevance Health | BOUDREAUX GAIL | Pres, CEO, Dir | F - Tax | $468.81 | -20.1K | 109.2K | -16% | -$9.42M |
| 2022-11-04 | 2022-11-04 | ELV | Elevance Health | BOUDREAUX GAIL | Pres, CEO, Dir | G - Gift | $0.00 | -10.0K | 111.4K | -8% | $0 | |
| 2022-03-10 | 2022-03-09 | TGT | Target Corporation | BOUDREAUX GAIL | Dir | A - Grant | $0.00 | +1,432 | 1,949 | +277% | $0 | |
| DM | 2022-03-03 | 2022-03-01 | ELV | Elevance Health | BOUDREAUX GAIL | Pres, CEO, Dir | A - Grant | $0.00 | +36.5K | 122.3K | +43% | $0 |
| DM | 2022-03-03 | 2022-03-01+ | ELV | Elevance Health | BOUDREAUX GAIL | Pres, CEO, Dir | F - Tax | $452.66 | -17.0K | 85.8K | -17% | -$7.69M |
| 2021-09-24 | 2021-09-23 | TGT | Target Corporation | BOUDREAUX GAIL | Dir | A - Grant | $0.00 | +514 | 514 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations